SOSV

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins the later rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

SOSV, established in 1994 and headquartered in United States, North America., specializes in Seed, Early Stage Venture, Late Stage Venture investments across Enterprise Software, Software, Service Industry, Insurance, Internet, Finance, Market Research, Robotics, Financial Services, FinTech. The organization boasts a portfolio of 2000+ investments, with an average round size of $11.4M and 77 successful exits. Their recent investments include Mapflow, SocialSci, Techstars, LaunchCapital, Techstars Ventures. The highest investment round they participated in was $561.5B. Among their most notable exits are Mapflow and SocialSci. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.